OBIO
Orchestra BioMed Holdings, Inc.
Key Financials
Net Income
$-52701000
↑ 13.6%
Operating Income
$-51807000
↑ 19.4%
Revenue
$33.5M
↑ 1169.2%
EPS (Diluted)
$-1.11
↑ 33.1%
Total Assets
$114.9M
↑ 50.8%
Cash & Equivalents
$34.7M
↑ 55.8%
Total Liabilities
$51.5M
↑ 19.1%
Long-term Debt
$15.0M
0.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 10/2/2026 | View on SEC |
| 144 | 10/1/2026 | View on SEC |
| 8-K | 10/1/2026 | View on SEC |
| 4 | 9/11/2026 | View on SEC |
| 8-K | 9/8/2026 | View on SEC |
| 4 | 9/8/2026 | View on SEC |
| 4 | 9/2/2026 | View on SEC |
| 144 | 9/1/2026 | View on SEC |
| 4 | 8/28/2026 | View on SEC |
| 4 | 8/28/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | OBIO |
| Company Name | Orchestra BioMed Holdings, Inc. |
| CIK | 1814114 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 646-343-9298 |